Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Small components play a large role in medical equipment

Several of the companies within the Lesjöfors Group have many years of experience supplying the medical industry. We would like to introduce some examples of spring products specially manufactured for this industry of current interest.Highly demanded medical components European Springs & Pressings in the UK is one of the Lesjöfors companies with customers in the medical industry. Their medical range includes springs that go into the mouthpieces for ventilators, catheter clips to syringe drivers, patient beds and trolley systems, instrumentation and numerous electrical components for

Alzinova publishes the Annual Report for 2019

The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the Annual Report of the financial year 2019.The Annual Report, which is attached in the press release, can also be downloaded from the company’s Swedish website, www.alzinova.se   For more information, please contact: Kristina Torfgård, CEO Telephone: +46 70 846 79 75 E-mail: kristina.torfgard@alzinova.com Certified Adviser: Corpura Fondkommission AB E-mail: ca@corpura.se Telephone: 0768-532822 Website: www.corpura.se   About Alzinova AB Alzinova AB is engaged in

AlzeCure Pharma publishes its Annual Report for 2019

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its Annual Report for 2019 has been published. The Annual Report is attached as a PDF and is available on the company’s website,For more information, please contact Martin Jönsson, CEO Tel: +46 707 86 94 43 martin.jonsson@alzecurepharma.com The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on April 15, 2020.  About AlzeCure Pharma AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in innovative drug research with a primary focus on

Invitation to conference call with web presentation of Cloetta AB´s interim report Q1 2020

Cloetta AB will publish the interim report for the period 1 January – 31 March 2020 on Friday 24 April 2020 at 8 a.m. CET. Following this report Cloetta will organize a conference call with web presentation for media and the financial community.President and CEO Henri de Sauvage Nolting and CFO Frans Rydén will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation. Time for the publication of the interim reportFriday 24 April at 08:00 a.m. CET  Time for conference call and web presentationFriday 24

KONE UltraRope® to feature in a new luxury hotel tower in Nanjing, China

KONE Corporation, press release, April 15, 2020 KONE Corporation, a global leader in the elevator and escalator industry, will deliver People Flow® solutions – including 36 elevators and the revolutionary KONE UltraRope® hoisting technology – to a new high-rise development in Nanjing, the capital of the Jiangsu province in eastern China.  The new building will rise up to 416.6 meters and host a Kimpton Hotel. It will become the tallest of the planned five high-rise buildings in the Nanjing Financial City Complex and the structurally tallest building in the entire city. Once

Elisa: Interim Report Q1 2020 publication on 22 April 2020

ELISA CORPORATION INVESTOR NEWS 15 APRIL 2020 AT 9:00 AMElisa will publish its Q1 2020 interim report from January–March on Wednesday 22 April 2020 at approximately 8:30 am EET (6:30 UK time). International conference call for analysts and investors will be held on the same day at 12:00 pm EET. Dial-in numbers for the conference call, PIN: 44230774#FI: +358981710310SE: +46 856642651UK: +44 3333000804US: +18558570686 Audiocast: https://elisa.videosync.fi/2020-q1-results The presentations will be available on elisa.com/investors  at

Elkem ASA – Notice of annual general meeting 2020

Oslo, 15 April 2020 The annual general meeting of Elkem ASA will be held on Friday 8 May 2020 at 09:00 (Norwegian time) at Felix Conference Centre, Bryggetorget 3, Vika in Oslo.  The full notice is attached, and all relevant documents can be found on www.elkem.com/investor This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.   For further information:Odd-Geir Lyngstad,VP Finance & Investor RelationsTel: +47 976 72 806Email: odd-geir.lyngstad@elkem.no About ElkemFounded in 1904, Elkem is one of

Hansa Biopharma to host conference call to provide interim results for the first quarter of 2020 and business update

Lund, Sweden April 15, 2020. Hansa Biopharma will publish its interim report for January-March 2020 at 8:00 a.m. CET on April 28, 2020. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 2:00 p.m. CET. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events & Webcast,” and will also be

Tobii’s Annual Report 2019 Available on the Website

Tobii AB (publ) has today published its Annual Report for 2019 on the website. The document includes Tobii's Sustainability Report and Corporate Governance Report. The Annual Report is available in Swedish and English on Tobii’s website under financial reports . The fiscal year covers the period January 1 to December 31, 2019. This information is information that Tobii AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication on April 15, 2020, at 08:00 a.m. CET.

Vicore Pharma publishes the Annual Report for 2019

Gothenburg, April 15, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announced the publication of the Annual Report 2019.The Annual Report is available on the company’s website: https://vicorepharma.com/investors/financial-reports/. For further information, please contact:Hans Jeppsson, CFO, tel: +46 70 553 14 65, hans.jeppsson@vicorepharma.com    This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the Securities Markets Act. The

Invitation to Kungsleden’s presentation of the first quarter 2020

On Thursday, 23 April 2020, at 7:00 a.m. (CET), Kungsleden AB (publ) will publish its interim report for January–March 2020.Accordingly, Kungsleden invites investors, asset managers, financial analysts and the press to a presentation of the interim report, where CEO Biljana Pehrsson and CFO Magnus Jacobsson will comment on the first quarter. The report will be published at 7:00 a.m. and will be available to download at www.kungsleden.se/financialreports Follow the presentation via telephone conference or audio broadcast at 8:45 a.m. The presentation will be held in English via a

Invitation to the presentation of Swedbank’s interim report January – March 2020

Swedbank’s interim report for January – March 2020 will be published on Thursday 23 Aprilat 7.00 a.m. (Swedish time).Investors and analysts: Conference call on 23 April at 8.00 a.m. (Swedish time)Jens Henriksson, President and CEO, Anders Karlsson, CFO, Lars-Erik Danielsson, Chief Credit Officer and Gregori Karamouzis, Head of Investor Relations will present the report. The conference call will be held in English and broadcasted live on www.swedbank.com/ir, where a recording also will be available following the call.To participate in the conference call, dial +46 8 566 42651 or +44

Trading update 1st quarter 2020

Medicover AB (publ)  issues a trading update due to Covid-19 crisis before it releases its interim announcement as planned on the 30[th] April 2020. · First quarter revenue reached €238.8m (€199.7m), up 19.6% on prior year with organic revenue growth of 5.8%. · Healthcare Services revenue reached €133.8m (€102.9m) up 30.1% on prior year with organic revenue growth of 6.3%. · Diagnostic Services revenue reached €108.1m (€100.2m) up 7.9% on prior year with organic revenue growth of 4.9%. · Operating profit was €6.4m (€11.3m) an operating margin of 2.7% (

Skanska builds part of the UK’s new high speed railway, HS2, for GBP 1.12 billion, about SEK 13.9 billion

Skanska, as part of the Skanska Costain STRABAG joint venture, has signed a contract with HS2 Ltd to commence full detailed design and construction of Phase 1 of the UK’s new high speed railway in the southern section of the overall project. Skanska will include GBP 1.12 billion, about SEK 13.9 billion, in the order bookings for Europe for the second quarter 2020.The contract involves the design and construction of major tunnels in the approach to the London terminus at Euston station. To date, the joint venture’s contract with HS2 Ltd has been to undertake scheme design and site

Konecranes publishes its January-March interim report on April 29, 2020

KONECRANES PLC PRESS RELEASE April 15, 2020 at 09:00 EEST Konecranes publishes its January-March interim report on April 29, 2020Konecranes will publish its January-March 2020 Interim Report on Wednesday, April 29, 2020 at 9.00 a.m. Finnish time. The report will be available on the company’s website at www.konecranes.com after publishing.A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 11:00 a.m. EEST. The event will be held in English. The January – March 2020 Interim report will be presented by CEO Rob Smith and

Outokumpu appoints Heikki Malinen as President and CEO

Outokumpu Oyj                                                       Stock exchange releaseApril 15, 2020 at 9.00 am EESTOutokumpu appoints Heikki Malinen as President and CEO Outokumpu’s Board of Directors has appointed Heikki Malinen, M.Sc. (Econ.), MBA (Harvard), as President and CEO of Outokumpu and the Chairman of the Leadership Team. He will join the company on May 1 and assume his role as the CEO on May 16, 2020. Heikki Malinen has previously worked as CEO in Posti Group Corporation and in Pöyry PLC. Prior to these, he has held various leadership positions in UPM in the USA and

Nordisk Film Games invests SEK 45 million into Nitro Games and becomes the largest shareholder

Nitro Games’ Board of Directors has resolved, subject to approval on the Annual General Meeting, on a SEK 45 million funding from Nordisk Film GamesThe board of directors of Nitro Games Oyj (publ) (“Nitro Games” or the “Company”) has resolved, subject to approval by shareholders at the Annual General Meeting (the “AGM”), on a funding package consisting of a directed new issue of 3,333,333 shares at a subscription price of SEK 7.5 per share, which is expected to raise proceeds of SEK 25.0 million to the Company before issue costs, and a convertible loan agreement, which is expected to raise

SpareBank 1 SR-Bank ASA (SRBANK): Postponement of final decision concerning the dividend for 2019

Reference is made to item 4 of the notice of the Annual General Meeting of SpareBank 1 SR-Bank ASA on 1 April 2020 concerning “Approval of the annual financial statements and annual report for 2019, including distribution of profit/loss for the year.”  The board of SpareBank 1 SR-Bank ASA considered the annual financial statements and annual report for 2019 at the board meeting held on 5 March 2020 and the annual report was published on the bank’s website prior to the Annual General Meeting. As stated in both its introduction and under item 4 of the notice, the board of SpareBank 1 SR-

Elekta receives CE mark approval for ProKnow web-based storage and retrieval software

STOCKHOLM, April 15, 2020 – Elekta (EKTA-B.ST) announced today that it has received CE mark for its ProKnow cloud-based retrieval and storage software, which features interactive viewers and big data analytics specifically designed for the radiation therapy workflow. With vendor-neutral ProKnow, any radiation therapy department can securely upload massive volumes of data to ProKnow’s cloud server for storage, distributed contouring, plan evaluation and peer review, analysis of key metrics – including outcomes – technique evaluations and intra- and inter-institutional collaborations.

Polygiene strengthens the organization in connection to the launch of ViralOff

In connection with the launch of ViralOff, a Polygiene product with antiviral properties, the company will strengthen the organization and bring on Andreas Holm who will focus on the new product and the inquiries that are pouring in. Andreas latest assignment was in the role as Nordic & Baltic Sales Director for Thule Group AB."To handle the pressure on the organization in connection with the launch of ViralOff, we have hired Andreas to lead special projects linked to the new product", says Ulrika Björk, CEO of Polygiene AB. "Andreas has a long and solid background from sport & outdoor and

Veidekke ASA: To construct new research and development building in Mölndal

Veidekke’s Swedish subsidiary BRA Bygg has been contracted to build new premises for FUJIREBIO in GoCo Health Innovation City, a health innovation cluster located in Mölndal, south of Gothenburg. The collaborative agreement with GoCo Health Innovation City has an estimated value of SEK 185 million.As the first building on the block, the 7,800 m[2] newbuild will be an important cog in the wheel of further development of the area. The building, scheduled for completion in the summer of 2021, will contain premises for research, production and development of analytical methods for cancer

Strong online sales – measures to address the effects of COVID-19 in focus

Sales in March decreased by 17 per cent compared to March last year, which corresponds to an organic sales decrease of 13 per cent. For the eleven-month period, organic sales growth in the Nordic countries was 3 per cent. Clas Ohlson’s online sales growth was 50 per cent in March and 22 percent for the eleven-month period.Organic sales in March decreased by 13 per cent compared with the previous year. Sales in comparable units and local currency decreased by 11 per cent. Total sales in March decreased by 17 per cent to 502 MSEK (605), which, in addition to COVID-19, was impacted by the

Ensuring staff and patient safety during the pandemic

In these times of challenge, infection control is more important than ever. Since safety has always been an integral part of our product design, we have compiled a set of useful materials designed to help dental clinics take care of their Planmeca equipment in a safe, smart and easy way.How to look after your Planmeca equipment before and after a period of inactivity As many dental clinics are currently going through or preparing for a temporary clinic closure, we have prepared specific guides to help them through all the procedures that should be performed on Planmeca’s dental, imaging

A more plant-based diet without stomach troubles: getting rid of FODMAPs with enzymes

Press release 15 March 2020 A plant-based diet is a good choice for both climate and health. However, many plant-based products, especially legumes, contain FODMAP compounds that are poorly digestible and cause unpleasant intestinal symptoms. A study by VTT and Finnish companies succeeded in breaking down FODMAPs with enzymes and producing new, stomach-friendly plant-based food products.FODMAPs are short-chain carbohydrate molecules that are poorly absorbed in the human small intestine. These non-absorbed compounds move along to the large intestine, where intestinal microbes feed on them.

There are no items matching the current filter
There are no more items matching the current filter
Back to top